SLIDE Insurance: Director Robert Gries Sells 84,636 Shares Under 10b5‑1 Plan While Stock Near 52‑Week Low
Insider Robert Gries’ scheduled 10b5‑1 sale of 84,636 SLIDE shares at $20.34 shows disciplined risk‑management, not distress, and may signal a solid valuation for long‑term investors.
3 minutes to read









